Results 191 to 200 of about 81,441 (250)

The therapeutic role of exercise training during menopause for reducing vascular disease

Experimental Physiology, Volume 111, Issue 6, Page 2813-2827, 1 June 2026.
Abstract Menopause marks a major milestone in female reproductive ageing. It is characterized by the cessation of ovarian function and a concomitant decline in hormones such as oestradiol. Subsequently, females undergoing menopausal transition experience a progressive increase in cardiovascular and cerebrovascular disease risk.
Conan L. H. Shing, Bert Bond, Kerrie L. Moreau, Jeff S. Coombes, Jenna L. Taylor   +4 more
wiley   +1 more source

Differential effects of pre-procedural atorvastatin versus rosuvastatin on hematologic and inflammatory markers in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized controlled trial. [PDF]

Am Heart J Plus
Khameneh Bagheri R, Eshraghi A, Amirsoleimani H, Keihanian F.   +3 more
europepmc   +1 more source

Calciprotein particle‐induced calcium overload triggers mitochondrial dysfunction in endothelial cells

The Journal of Physiology, Volume 604, Issue 11, Page 4186-4207, 1 June 2026.
Abstract figure legend Calciprotein particles (CPPs) are small calcium‐ and phosphate‐containing nanoaggregates associated with the development of vascular disease (CVD) in chronic kidney disease (CKD). Previously, we have shown that CPPs induce endothelial cell (EC) dysfunction, possibly contributing to CVD in CKD, but the underlying molecular ...
Lian Feenstra, Laurent Chatre, Benoit Bernay, Julien Pontin, Mirjam F. Mastik, Azuwerus van Buiten, Dalibor Nakládal, Bastiaan S. Star, Jan‐Luuk Hillebrands, Guido Krenning   +9 more
wiley   +1 more source

Single catheter strategy for transradial angiography and primary percutaneous coronary intervention enhances procedural efficiency, microvascular outcomes, and cost-effectiveness: Implications for STEMI healthcare in resource-limited settings. [PDF]

PLoS One
Arneja M, Gunasekar S, Narayanan DH, Joseph J, Kovvuri H, Shanmugam S, Kumar PS, Anandaram A, Balakrishnan VK, Balasubramaniyan JV, Shanmugasundaram S, Ramesh S, Senguttuvan NB.   +12 more
europepmc   +1 more source

Comparative Benefits of Primary Percutaneous Coronary Intervention Versus Onsite Fibrinolytic for Patients With ST-Segment-Elevation Myocardial Infarction: A Quasi-Experimental Study. [PDF]

J Am Heart Assoc
Zhou S, Xie S, You B, Xiang D, Fang W, Trisolini MG, Labresh KA, Smith SC, Zheng ZJ, Jin Y, Liu F, Huo Y.   +11 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Cardiac magnetic resonance assessment of long-term cardiac function after early recombinant staphylokinase thrombolysis before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction patients. [PDF]

Quant Imaging Med Surg
Gong H, Wang Y, Li C, Yin J, Chen P, Wang J, Zhou Y, Zhu X, Li C, Xu Y.   +9 more
europepmc   +1 more source

Prophylactic Beta-Blocker Therapy in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Affas Z, Patel K, Abuzahrieh OR, Al Barznji S, Walji M, Touza R, Albanna M, Zughaib M.   +7 more
europepmc   +1 more source

Pharmaco-Invasive Strategy with Half-Dose Recombinant Human Prourokinase Versus Primary Percutaneous Coronary Intervention. [PDF]

Anatol J Cardiol
Jiang C, Dou J, Yang H, Guo R, Gao J, Liu B, Shu H, Hou Y, Zhao L, Guo J, Luo D.   +10 more
europepmc   +1 more source

Prognostic Value of Myocardial Blush Grade in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Coronary Intervention (PCI): Association With Reperfusion Success and In-Hospital Outcomes. [PDF]

Cureus
Khan SW, Ahtesham M, Azim FE, Sajid M, Fayyaz A, Ullah I, Khan Z.   +6 more
europepmc   +1 more source